A B S T R A C T To study possible mechanisms responsible for the increased susceptibility to infection of patients with active systemic lupus erythematosus (SLE), a study of the serum heat-labile opsonic capacity (HLOC) in such patients was undertaken. With leukocytes from normal donors, the sera of 12 of 30 patients with active SLE demonstrated decreased HLOC for E. coli 075. The phagocytic activity was partially restored by normal serum, suggesting that decreased HLOC was responsible for the defective phagocytosis. While 8 of 10 patients with active SLE and concomitant infections showed deficient opsonic capacity to E. coli 075, only 4 of 20 such patients without infections showed the defect (P = 0.01). None of 12 patients with inactive disease had deficient opsonic capacity. Similar results were obtained with S. aureus 502A as the test bacterium. In the patients surviving infection, recovery of normal serum opsonic capacity was rapid and usually coincided with an increase of serum complement to normal levels.
INTRODUCTION
The increased susceptibility of patients with active systemic lupus erythematosus (SLE)1 to bacterial and mycotic infections has been well documented (1) (2) (3) (4) (5) (6) (7) (8) . Al- though the introduction of corticosteroid therapy may currently be a contributing factor, infections constituted a frequent cause of death in the precorticosteroid era (1) (2) (3) (4) (5) . Furthermore, infections frequently occur at times of overt clinical activity (8) .
The possible causes of the increased susceptibility to infections in SLE are not known. Nevertheless, some of the known cellular and humoral derangements found in this disease may provide a pathophysiologic mechanism. A decrease in IgM antibody titers to bacterial antigens has been reported by Baum and Ziff (9) . De- ficient cellular phagocytic function may play a role 1 Abbreviations used in this paper: C3PA, C3 proactivator; C'H50, hemolytic complement; HLOC, heat-labile opsonic capacity; SLE, systemic lupus erythematosus. (10) , since leukopenia and cytotoxic antibodies to circulating white cells are commonly present in active SLE (11, 12) . Furthermore, low serum complement levels are characteristic of active SLE; and this acquired deficiency may also be responsible for increased susceptibility to infection (13) .
Since the development of an infectious episode may depend on the early events after invasion by the infectious agent, nonspecific defense mechanisms, independent of specific antibody may be of particular importance in the susceptibility to infection in this disease. Therefore, a study of the phagocytic function mediated by the serum heat-labile opsonin system was undertaken in patients with SLE. It was considered desirable to study the heat-labile opsonin system, because complement components are known to participate in its action (14) (15) (16) (17) and because heat-labile opsonization of bacteria and fungi, presumably in the absence of specific antibodies 
METHODS
Clinical material. Serum was obtained as far as was possible from every patient with SLE admitted to Parkland Memorial Hospital, Dallas, during the period of this study. In addition, random serum specimens were obtained from patients attending the outpatient department. A total of 34 patients were studied. Of these, 8 were included at different times in both the active and inactive disease groups. Donors of normal serum and blood leukocytes were either laboratory workers or patients admitted to the orthopedic wards with no evidence of systemic disease.
Criteria for SLE activity. Clinical manifestations of SLE, such as the presence of fever not responding to antibiotic therapy, skin rash, arthritis, serositis, glomerulonephritis, organic psychosis, and focal neurological signs were used to arrive at the diagnosis of SLE activity. 30 of the patients studied were considered to be clinically active (Table I) . Serum complement levels were low in 27 of these patients. 12 of the active patients were untreated at the time of testing. The rest were treated with corticosteroids, in daily dosage ranging from 10 to 100 mg of prednisolone. Two patients received cyclophosphamide for 3 and 7 days before testing HLOC (Table I) In vitro phagocytosis of E. coli 075 with 5% normal serum and blood leukocytes from 23 normal subjects. Brackets indicate +SEM. Notice the absence of phagocytosis when sera were previously, heated at 560C for 30 min, when leukocytes were omitted, and when tubes were kept at 4VC or not rotated.
As shown in Fig. 1 , the number of bacteria in the heated controls increased over the baseline tubes kept at 40C, indicating that growth occurred during the 2-h incubation period. Similarly, in controls omitting leukocytes or rotating motion, which were included to ensure that the decrease in the number of bacteria was not due to serum bactericidal activity, no evidence of such bactericidal activity was detected in the 17 normal sera so tested.
In order to rule out the possibility that the abnormal phagocytic function measured in patients with active SLE was due to a decrease in phagocytic activity by the patients' leukocytes, as has been reported (10), normal leukocyte donors were used in all the experiments reported here. Since the leukocytes were centrifuged at the end of the incubation period, an effort was made to rule out possible cosedimentation of bacteria attached to leukocytes or the presence of live intracellular microorganisms. In five experiments using leukocytes from controls or patients with SLE, the cells were resuspended, lysed in water, and tested for the presence of viable bacteria. In all cases, bacteria were not detected, indicating that they were killed rapidly after phagocytosis.
The possibility that the sera from SLE patients contained a cytotoxic factor for leukocytes (11, 12) was also ruled out. Addition of equal volumes of normal serum to heat-labile opsonin-deficient SLE serum resulted in almost complete restoration of opsonic capacity in 12 of 16 experiments. Fig. 2 shows the average results obtained for the 16 experiments. After 2 h of incubation, there was an average decrease of more than 90% of the initial number of bacteria.
HLOC of normal sera, sera from patients with miscellaneous acute infections, and SLE sera from patients with and without infections are shown in Fig. 3 , after 1 and 2 h of incubation with E. coli 075 as the test bacterium. There were 10 patients with active SLE and concomitant infectious episodes (see Table I infection, as will be discussed below. Of the remaining 20 active patients without infection, only 4 had decreased HLOC (P 0.01) and none of 12 inactive SLE patients had deficient opsonic capacity.
Similar results were obtained with S. aurcus 502A as the test bacterium (Table II) . HLOC was tested at two different serum concentrations; in each case there was a statistically significant difference between the opsonic capacity of normal sera and a group of six sera from patients with active SLE and concomitant infections.
Sera from five patients with a variety of acute bacterial infections but without SLE were also tested against both E. coli 075 (Fig. 3) and S. aureus 502A; these showed normal HLOC in every case.
In Table I are summarized the HLOC and the clinical and laboratory findings in the group of 30 patients with active SLE studied. Although the average serum hemolytic complement (C'H50) and C3 values (Table III) and blood leukocyte counts were lower in the group of patients with concomitant infection than in the group without infection, the differences were not statistically significant (P > 0.1) in each case. However, when comparison was made between the groups with low and normal HLOC, the differences between the mean C'H50 and C3 levels of the two groups were in each case statistically significant (P < 0.05), while average leukocyte counts and corticosteroid dosages did not differ significantly (P > 0.1), indicating that the patients with low opsonic capacity tended to have lower serum complement levels. This impression was confirmed by regression analysis of the data. When HLOC and serum C3 levels of 49 sera from all groups were compared, a correlation coefficient of 0.695 (P < 0.001) was obtained, indicating that a positive correlation existed between serum opsonin and C3 levels (Fig. 4) .
HLOC of SLE patients during and after infection. Table IV shows the opsonic capacity and C3 levels of (28) and was avirulent when inoculated in guinea pigs and rats. Unlike virulent P. pneunioniae (29), the isolated organism was easily opsonized at low concentrations of normal serum. However, the early serum of D. J. showed deficient HLOC for the isolated type 19 Pneumococcus (Fig. 5) as well as for E. coli 075 (Table IV) . 11 days later, after recovery from the infection and control of the SLE activity, opsonic capacities for both the isolated Pneumococcus and E. coli 075 returned to normal. It is of interest that a second serum drawn 11 days later developed heat-stable opsonic capacity towards the isolated organism, indicating the appearance of specific antibody.
Patient B. P. developed E. coli meningitis and septicemia after admission to the hospital for an exacerbation of lupus glomerulonephritis. Her serum was unable to opsonize the isolated organism, while HLOC for E. coli 075 was found to be normal (Fig. 6 ). It should be pointed out that the E. coli isolated from this patient needed a higher concentration of normal serum for optimal opsonization. Subsequent sera developed bacteri- (Fig. 7) Table V  2 included the addition of human C1, C4, C2, and C5 separately, together or in sequence. When these were added in x from patient sequence, the bacteria were washed after incubation with I from the pa-Cl, and then C4, C2, C3, and C5 were added. No inlotted line ndi-crease in HLOC was observed. Addition of C3PA and y sera for both purified C3 together to three deficient sera failed to red the test bac-store activity. Addition of hydrazine-treated or zymosanincubated serum also failed to restore activity. To rule The role of the alternate pathway of complement in the opsonization of one of the bacteria isolated from infected patients was studied in detail. Fig. 9 shows the results obtained for the E. coli isolated from patient B. P. Normal serum heated at 50'C for 40 min lost its opsonic capacity for the E. coli tested. Complete restoration of activity could be achieved by the addition of The present work has shown that phagocytosis by normal polymorphonuclear cells was deficient when tested with diluted serum of patients with active SLE and concomitant infection. This defect was observed in the sera of 8 of 10 such patients studied. Evidence was obtained that a decrease in serum heat-labile opsonin concentration was in fact responsible for the defect. It was also shown that the defect in phagocytosis was not due to the presence of leukocytotoxic antibodies (6, 7) in the deficient SLE sera by the successful restoration of opsonic capacity upon addition of normal serum in 12 of 16 experiments. The less than complete restoration observed with occasional sera of this group may have been due to consumption of critical complement components of the added normal serum during the 1 and 2-h phagocytosis periods by the active SLE sera present, since the latter are known to contain immune complexes and to be anti-complementary (31) . This possibility is also suggested by observations made on two sera (J. A. and M. H., Table V) whose opsonic capacity was not completely restored by normal serum. Addition to these sera of 50'C-heated serum and an amount of C3PA that yielded a final concentration in the high physiologic range resulted in more intense phagocytic activity.
In 9 of 10 patients with active SLE and infection, serum heat-labile opsonization was found to be defi-cient either against E. coli 075 or the microorganisms responsible for the infectious episode. In contrast, only 4 (8) that the more active patients were most likely to become infected, the differences were not statistically significant. However, when C'H50 and C3 levels were compared in those with low and those with normal HLOC, the differences were statistically significant, indicating that the patients with low serum complement levels tended to have low HLOC. This impression was confirmed by the positive correlation obtained between serum C3 levels and HLOC in both normal and SLE sera. Since the mean corticosteroid dosage of the patients with infection was appreciably lower than in those without infection and since in all cases tested HLOC levels rose to normal as disease activity was controlled by adequate doses of corticosteroids, it is possible that the lower complement levels seen in the patients with low HLOC may have been a result of increased clinical activity due to the lower dosage taken by these patients before the onset of active disease.
If HLOC plays an important role in the defense against infection, particularly in the early "preantibody phase," it would be expected that the causative microorganisms would not be opsonized by the patient's serum at the time of infection but would be susceptible to opsonization in the presence of normal serum. This was the case with all three bacteria isolated from infected patients. Subsequently, heat-stable opsonins or bactericidal activity directed only to the infecting organism eventually appeared in two of the patients, indicating the emergence of specific serum antibodies. However, the finding in initial and early sera of decreased HLOC for the test bacteria employed and for the specific organisms isolated from infected patients indicates that low serum HLOC may contribute directly to the increased susceptibility to infection of patients with active SLE.
Since it is likely that whether an infection develops may depend on the early events after invasion by the infectious agent. the contribution of nonspecific defense mechanisms such as serum HLOC should be of particular importance at this stage. That heat-labile opsonins may mediate phagocytosis of some infectious agents in the early, pre-antibody period of infection is indicated by several studies (18) (19) (20) (32) (33) (34) . This impression is reinforced by the failure in the present experiments to restore heatlabile opsonin activity by the addition of the isolated components of the classical pathway, C1, C4, C2, C3, and C5 either separately, together, or in sequence. Furthermore, addition of a reagent such as 50'C-heated normal serum plus functionally pure C2, which presumably contains near normal amounts of the classical pathway components (18) , failed to restore opsonic capacity in the SLE sera. In the case of one of the three microorganisms isolated, direct evidence that opsonization was mediated via the alternate pathway was observed in the restoration of HLOC to 50'C-heated normal serum by addition of purified C3PA.
Ancillary evidence for the depletion of components of the alternate pathway was provided by the finding of subnormal C3PA levels in 9 of 11 sera with deficient HLOC. That low serum C3PA was not the unique factor responsible for the defect was evident from the fact that SLE sera with normal opsonic capacity also showed similarly decreased levels. In fact, addition of purified C3PA alone to five deficient sera failed to increase HLOC in all instances, indicating that other factors of the alternate pathway, presumably acting in the earlier activation steps, were also functionally depleted. The factors provided by the 50°C-heated serum seemed to be critical in the case of patients J. G. and J. W. (Table V) Several patients with congenital absence of complement components and increased susceptibility to infection have been reported in recent years (13, (36) (37) (38) (39) . In one case (36, 37) , absence of C3 inactivator allowed generation of active C3 (factor A), which in turn resulted in abnormal activation of the alternate pathway with depletion of its components including the opsonic agent C3. In the case of active SLE, consumption of complement components appears to result in a similar defect leading to a decrease in HLOC. On the same basis, other related complement-mediated functions linked to the activation of C3, such as the complement-dependent generation of chemotactic factors for polymorphonuclear leukocytes (40) (41) (42) (43) , may also be deficient in SLE.
It is unlikely that the observed decrease in HLOC of active SLE sera from patients with concomitant infections is the consequence of the infection rather than an antecedent event for a number of reasons: (a) There were 4 patients in the group of 20 without infection who also had low HLOC. (b) In the case of one patient with lobar pneumonia, HLOC remained low for 3 wk after successful treatment of the pneumonia and became normal only after treatment with prednisolone and subsidence of clinical activity and elevation of the serum complement to normal levels. (c) Decreased HLOC was observed in a number of sera obtained before overt clinical evidence of infection. (d) Others have observed a decrease in complement-dependent functions (42, 43) and in serum levels of some components of the alternate pathway (32) (33) (34) (35) in SLE, presumably in the absence of infection.
